570 related articles for article (PubMed ID: 21749385)
1. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.
Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L
J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385
[TBL] [Abstract][Full Text] [Related]
2. Development of pegylated liposomal vinorelbine formulation using "post-insertion" technology.
Li CL; Cui JX; Wang CX; Zhang L; Li YH; Zhang L; Xiu X; Li YF; Wei N
Int J Pharm; 2010 May; 391(1-2):230-6. PubMed ID: 20214962
[TBL] [Abstract][Full Text] [Related]
3. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
4. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
5. Impact of interfacial cholesterol-anchored polyethylene glycol on sterol-rich non-phospholipid liposomes.
Cui ZK; Edwards K; Nieto Orellana A; Bastiat G; Benoit JP; Lafleur M
J Colloid Interface Sci; 2014 Aug; 428():111-20. PubMed ID: 24910042
[TBL] [Abstract][Full Text] [Related]
6. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
7. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
[TBL] [Abstract][Full Text] [Related]
8. The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator.
Kim JY; Kim JK; Park JS; Byun Y; Kim CK
Biomaterials; 2009 Oct; 30(29):5751-6. PubMed ID: 19656559
[TBL] [Abstract][Full Text] [Related]
9. Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulation.
Li C; Cui J; Wang C; Li Y; Zhang L; Xiu X; Li Y; Wei N; Zhang L; Wang P
J Pharm Pharmacol; 2011 Jun; 63(6):765-73. PubMed ID: 21585373
[TBL] [Abstract][Full Text] [Related]
10. Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?
Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Xiu X; Li Y; Wei N
J Pharm Sci; 2011 Jul; 100(7):2835-48. PubMed ID: 21305545
[TBL] [Abstract][Full Text] [Related]
11. Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes.
Hossann M; Syunyaeva Z; Schmidt R; Zengerle A; Eibl H; Issels RD; Lindner LH
J Control Release; 2012 Sep; 162(2):400-6. PubMed ID: 22759980
[TBL] [Abstract][Full Text] [Related]
12. Sulfosalicylate mediates improved vinorelbine loading into LUVs and antineoplastic effects.
Li C; Cui J; Wang C; Cao J; Zhang L; Li Y; Liang M; Xiu X; Li Y; Wei N; Deng C
J Liposome Res; 2012 Mar; 22(1):42-54. PubMed ID: 21696260
[TBL] [Abstract][Full Text] [Related]
13. Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity.
Semple SC; Leone R; Wang J; Leng EC; Klimuk SK; Eisenhardt ML; Yuan ZN; Edwards K; Maurer N; Hope MJ; Cullis PR; Ahkong QF
J Pharm Sci; 2005 May; 94(5):1024-38. PubMed ID: 15793796
[TBL] [Abstract][Full Text] [Related]
14. Lipid composition and grafted PEG affect in vivo activity of liposomal mitoxantrone.
Li C; Cui J; Wang C; Wang J; Li Y; Zhang L; Zhang L; Guo W; Wang Y
Int J Pharm; 2008 Oct; 362(1-2):60-6. PubMed ID: 18598745
[TBL] [Abstract][Full Text] [Related]
15. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
[TBL] [Abstract][Full Text] [Related]
16. The in vitro characterisation and biodistribution of some non-ionic surfactant coated liposomes in the rabbit.
Khattab MA; Farr SJ; Taylor G; Kellaway IW
J Drug Target; 1995; 3(1):39-49. PubMed ID: 7655819
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method.
Qiu L; Jing N; Jin Y
Int J Pharm; 2008 Sep; 361(1-2):56-63. PubMed ID: 18573626
[TBL] [Abstract][Full Text] [Related]
18. Novel liposomal gefitinib (L-GEF) formulations.
Zhou X; Yung B; Huang Y; Li H; Hu X; Xiang G; Lee RJ
Anticancer Res; 2012 Jul; 32(7):2919-23. PubMed ID: 22753756
[TBL] [Abstract][Full Text] [Related]
19. Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention.
Zhigaltsev IV; Maurer N; Akhong QF; Leone R; Leng E; Wang J; Semple SC; Cullis PR
J Control Release; 2005 May; 104(1):103-11. PubMed ID: 15866338
[TBL] [Abstract][Full Text] [Related]
20. Application of liposome encapsulation technique to improve anti-carcinoma effect of resveratrol.
Lu XY; Hu S; Jin Y; Qiu LY
Drug Dev Ind Pharm; 2012 Mar; 38(3):314-22. PubMed ID: 21851312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
